Form 8-K - Current report:
SEC Accession No. 0001104659-25-024432
Filing Date
2025-03-17
Accepted
2025-03-17 16:20:16
Documents
16
Period of Report
2025-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259453d1_8k.htm   iXBRL 8-K 30421
2 EXHIBIT 99.1 tm259453d1_ex99-1.htm EX-99.1 11843
7 GRAPHIC tm259453d1_ex99-1img001.jpg GRAPHIC 11238
  Complete submission text file 0001104659-25-024432.txt   275194

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA elan-20250311.xsd EX-101.SCH 3254
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20250311_def.xml EX-101.DEF 26569
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20250311_lab.xml EX-101.LAB 36011
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20250311_pre.xml EX-101.PRE 25184
18 EXTRACTED XBRL INSTANCE DOCUMENT tm259453d1_8k_htm.xml XML 4302
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 25744760
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)